Retour à la page sur Thealoz® Duo
1. Fariselli C, et al. Trehalose/hyaluronate eyedrop effects on ocular surface inflammatory markers and mucin expression in dry eye patients. Clinical Ophthalmology. 2018;12:1293–1300.
2. Teramoto N, et al. Trehalose and trehalose-based polymers for environmentally benign, biocompatible and bioactive materials. Molecules. 2008;13(8):1773-816.
3. Cejkova J, et al. Trehalose treatment accelerates the healing of UVB-irradiated corneas. Comparative immunohistochemical studies on corneal cryostat sections and corneal impression cytology. Histol Histopathol. 2012;27(8):1029-40.
4. Jain NK, Roy I. Effect of trehalose on protein structure. Protein Sci. 2009;18(1):24–36.
5. Baudouin C, et al. Role of hyperosmolarity in the pathogenesis and management of Dry Eye Disease: Proceedings of the OCEAN Group Meeting. Ocul Surf. 2013;11(4):246-58.
6. Li J, et al. Therapeutic efficacy of trehalose eye drops for treatment of murine dry eye induced by an intelligently controlled environmental system. Mol Vis. 2012;18:317-2.
7. Troiano P, and all. Effect of hypotonic 0.4% Hyaluronic acid drops in dry eye patients: a cross-over study. Cornea. 2008.
8. Schmidl D, et al. Tear film thickness after treatment with artificial tears in patients with moderate dry eye disease. Cornea. 2015;34(4):421-6.
9. Chiambaretta F, et al. A randomized, controlled study of the efficacy and safety of a new eyedrop formulation for moderate to severe dry eye syndrome. Eur J Ophthalmol. 2016.
